Literature DB >> 29106926

Increasing Prevalence of Hepatitis C among Hospitalized Children Is Associated with an Increase in Substance Abuse.

A Sidney Barritt1, Brian Lee2, Thomas Runge1, Monica Schmidt3, Ravi Jhaveri4.   

Abstract

OBJECTIVE: To evaluate the impact of substance abuse on pediatric hepatitis C virus (HCV) prevalence, we examined geographic and demographic data on inpatient hospitalizations in children with HCV. STUDY
DESIGN: We examined hospitalizations in children using the Kids' Inpatient Database, a part of the Healthcare Cost and Utilization Project. We identified cases using the International Classification of Diseases, 9th edition, codes for HCV infection during 2006, 2009, and 2012. Nonparametric tests for trend were used to calculate trend statistics.
RESULTS: From 2006 to 2012 nationally, the number of hospitalizations of children with HCV increased 37% (2.69 to 3.69 per 10 000 admissions; P < .001). The mean age of children hospitalized was 17.6 years (95% CI, 17.4-17.8). HCV cases among those 19-20 years of age represented 68% of the total HCV diagnoses, with a 54% increase over the years sampled (P < .001 for trend). The burden of HCV in children was highest in whites, those in the lowest income quartile, and in the Northeast and Southern regions of the US (all P < .0001). The prevalence of substance use among children with HCV increased from 25% in 2006 to 41% in 2012 (P < .001).
CONCLUSION: The increases of HCV in hospitalized children are largely in teenagers, highly associated with substance abuse, and concentrated in Northeast and Southern states. These results strongly suggest that public health efforts to prevent and treat HCV will also need to include adolescents.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hepatitis C; inpatient; pediatrics; prevalence; substance abuse

Mesh:

Year:  2017        PMID: 29106926     DOI: 10.1016/j.jpeds.2017.09.016

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  12 in total

1.  Charges for Alcoholic Cirrhosis Exceed All Other Etiologies of Cirrhosis Combined: A National and State Inpatient Survey Analysis.

Authors:  A Sidney Barritt; Yue Jiang; Monica Schmidt; Paul H Hayashi; Ramon Bataller
Journal:  Dig Dis Sci       Date:  2019-01-23       Impact factor: 3.199

Review 2.  Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018.

Authors:  Anne F Peery; Seth D Crockett; Caitlin C Murphy; Jennifer L Lund; Evan S Dellon; J Lucas Williams; Elizabeth T Jensen; Nicholas J Shaheen; Alfred S Barritt; Sarah R Lieber; Bharati Kochar; Edward L Barnes; Y Claire Fan; Virginia Pate; Joseph Galanko; Todd H Baron; Robert S Sandler
Journal:  Gastroenterology       Date:  2018-10-10       Impact factor: 22.682

3.  Attitudes, practices and perceived barriers to hepatitis C screening among medical residents at a large urban academic medical center.

Authors:  Daniel Winetsky; Jason Zucker; Caroline Carnevale; Deborah Theodore; Matthew Scherer; Fereshteh Sani; Katherine Elkington; Alwyn Cohall; Magdalena E Sobieszczyk; Peter Gordon; Susan Olender
Journal:  J Viral Hepat       Date:  2019-08-09       Impact factor: 3.728

Review 4.  Defer no more: advances in the treatment and prevention of chronic hepatitis C virus infection in children.

Authors:  Jonathan R Honegger; Charitha Gowda
Journal:  Curr Opin Infect Dis       Date:  2022-07-15       Impact factor: 4.968

Review 5.  Hepatitis C models of care: approaches to elimination.

Authors:  Mia J Biondi; Jordan J Feld
Journal:  Can Liver J       Date:  2020-06-04

Review 6.  New Face of Hepatitis C.

Authors:  Tiffany Wu; Peter G Konyn; Austin W Cattaneo; Sammy Saab
Journal:  Dig Dis Sci       Date:  2019-02-13       Impact factor: 3.487

7.  Report from the International Viral Hepatitis Elimination Meeting (IVHEM), 17-18 November 2017, Amsterdam, the Netherlands: gaps and challenges in the WHO 2030 hepatitis C elimination framework.

Authors:  Stephanie Popping; Manal El-Sayed; Jordan Feld; Angelos Hatzakis; Margaret Hellard; Olufunmilayo Lesi; Michael Ninburg; John Ward; Charles Boucher
Journal:  J Virus Erad       Date:  2018-07-01

8.  Screening for Hepatitis C Virus: How Universal Is Universal?

Authors:  Ravi Jhaveri
Journal:  Clin Ther       Date:  2020-07-23       Impact factor: 3.393

Review 9.  Hepatitis C virus infection in children in the era of direct-acting antiviral.

Authors:  Malgorzata Pawlowska; Malgorzata Sobolewska-Pilarczyk; Krzysztof Domagalski
Journal:  World J Gastroenterol       Date:  2018-06-28       Impact factor: 5.742

Review 10.  Pediatric Consultation-Liaison Psychiatry: An Update and Review.

Authors:  Jessica E Becker; Joshua R Smith; Eric P Hazen
Journal:  Psychosomatics       Date:  2020-04-25       Impact factor: 2.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.